BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3421780)

  • 1. Interaction of 2,4-diaminopyridine with cholinesterase inhibitors.
    Biessels PT; Houwertjes MC; Agoston S; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():228-35. PubMed ID: 3421780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neostigmine, edrophonium, 4-aminopyridine and their combinations.
    Treffers R; Frankhuyzen AL; Booij LH
    Acta Anaesthesiol Belg; 1988; 39(1):55-8. PubMed ID: 2835880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of nifedipine and diltiazem with muscle relaxants and reversal of neuromuscular blockade with edrophonium and neostigmine.
    Wali FA
    J Pharmacol; 1986; 17(3):244-53. PubMed ID: 3795969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation between neostigmine and 3,4-diaminopyridine in antagonizing the neuromuscular block induced by D-tubocurarine.
    Chang CC; Su MJ; Shieh BH; Lin HL; Hong SJ
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):235-9. PubMed ID: 6100937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
    Wali FA
    Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium.
    Bartkowski RR
    Anesth Analg; 1987 Jul; 66(7):594-8. PubMed ID: 3605668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.
    Miller RD; Dennissen PA; van der Pol F; Agoston S; Booij LH; Crul JF
    J Pharm Pharmacol; 1978 Nov; 30(11):699-702. PubMed ID: 31433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some actions of Org NC 45 and of edrophonium in the anaesthetized cat and in man.
    Baird WL; Bowman WC; Kerr WJ
    Br J Anaesth; 1982 Apr; 54(4):375-85. PubMed ID: 6121569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
    Donati F; Ferguson A; Bevan DR
    Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs.
    Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K
    Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.
    Backman SB; Stein RD; Blank DW; Collier B; Polosa C
    Can J Anaesth; 1996 Jul; 43(7):731-40. PubMed ID: 8807181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aminopyridine potentiates neostigmine and pyridostigmine in man.
    Miller RD; Booij LH; Agoston S; Crul JF
    Anesthesiology; 1979 May; 50(5):416-20. PubMed ID: 453559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.
    Okamoto M; Walewski JL; Artusio JF; Riker WF
    Anesth Analg; 1992 Sep; 75(3):361-71. PubMed ID: 1324625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of pancuronium and tubocurarine blocks by edrophonium or neostigmine: a comparative study.
    Mirakhur RK
    Eur J Anaesthesiol; 1987 Nov; 4(6):411-9. PubMed ID: 3446491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block.
    Naguib M; Abdulatif M
    Anesth Analg; 1994 Feb; 78(2):306-11. PubMed ID: 8311284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potencies of edrophonium and neostigmine as antagonists of pancuronium.
    Breen PJ; Doherty WG; Donati F; Bevan DR
    Anaesthesia; 1985 Sep; 40(9):844-7. PubMed ID: 4051150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.